- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE, RadNet to Analyze Breast Cancer Detection Processes
GE Healthcare and RadNet have partnered to identify the most efficient, cost-effective approaches for breast cancer detection.
GE Healthcare and RadNet have partnered to identify the most efficient, cost-effective approaches for breast cancer detection.
Together, they will pilot test GE’s Best Pathways initiative, a breast cancer model designed to analyze clinical breast cancer detection processes, pinpoint inefficient diagnostic patterns, and discover the best ways to control costs while improving patient outcomes, both companies announced.
Best Pathways, targeted to women for whom there are few screening guidelines and frequent disparities in clinical practice, is intended to tackle the need for greater understanding around the breast cancer detection process from first screening mammograms to last biopsies.
Initiative plans include:
• determining the diagnostic cost per detected cancer,
• categorizing the types of breast cancers detected and their stage distribution,
• quantifying the number of imaging tests and biopsies needed to find each cancer, and
• determining the cost-effectiveness ratios per diagnostic case.
Patient population characteristics, such as age, risk of breast cancer development, and breast density, will be used to identify diagnostic patterns.
Previously published research in BMC Cancer revealed late diagnosis, decreased initial treatments and race are the main factors for mortality differences between wealthy and low-income breast cancer patients. The study called for more interventions targeted toward populations that lacked sufficient breast cancer services.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.
